Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern

Misonix Schedules First Quarter 2010 Financial Results Conference Call;
November 16, 2009 at 4:30 p.m. Eastern

FARMINGDALE, N.Y., Nov. 12 /PRNewswire/ -- Misonix, Inc. (Nasdaq: MSON), a
developer of minimally invasive ultrasonic medical device technology, which in
Europe is used for the ablation of tumors and worldwide for other acute health
conditions, today announced plans to release first quarter ended September 30,
2009 financial results on Monday afternoon, November 16, 2009. Michael A.
McManus, President and Chief Executive Officer and Richard Zaremba, Senior VP
and Chief Financial Officer, will host a conference call at 4:30 p.m. Eastern
on Monday, November 16, 2009 to discuss the Company's first quarter 2010
financial results.

Shareholders and other interested parties may participate in the conference
call by dialing (866) 711-8198 (domestic) or (617) 597-5327 (international)
and entering access code 95855392, a few minutes before the start of the call.
A simultaneous webcast will be available via Misonix's website at
www.misonix.com. The call will be archived on the Company's website for at
least 90 days.

A recording of the live-call will be available approximately 2 hours after the
event through November 23, 2009. The dial-in number to listen to the recording
is (888) 286 8010 or (617) 801 6888. The replay access code is 44023008.

About Misonix:
Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets
therapeutic ultrasonic medical devices and laboratory equipment. Misonix's
therapeutic ultrasonic platform is the basis for several innovative medical
technologies. Addressing a combined market estimated to be in excess of $3
billion annually; Misonix's proprietary ultrasonic medical devices are used
for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery,
and other surgical and medical applications. Additional information is
available on the Company's Web site at www.misonix.com.

Investor Relations Contact:
Kevin M. McGrath
Cameron Associates, Inc.
212 245 4577
Kevin@cameronassoc.com

SOURCE Misonix, Inc.

Richard Zaremba, Chief Financial Officer of Misonix, +1-631-694-9555,
invest@misonix.com; or Investor Relations, Kevin M. McGrath of Cameron
Associates, Inc., +1-212-245-4577, Kevin@cameronassoc.com